Mediclin AG

Mediclin AG’s 2025 results show steady growth, with 4.8% revenue rise and 3.5% EBIT increase, confirming its rehabilitation strategy and solidifying a strong foundation for 2026.

Mediclin AG reports 5.1% sales growth and rising operating profits in the first nine months of 2025, driven by a 9.3% rise in post‑acute services and tighter material costs.